Literature DB >> 29987126

The ceramide ratio: a predictor of cardiometabolic risk.

Trevor S Tippetts1, William L Holland1, Scott A Summers2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29987126      PMCID： PMC6121923          DOI： 10.1194/jlr.C088377

Source DB:  PubMed          Journal:  J Lipid Res        ISSN： 0022-2275            Impact factor:   5.922


× No keyword cloud information.
  12 in total

Review 1.  Ceramide synthases as potential targets for therapeutic intervention in human diseases.

Authors:  Joo-Won Park; Woo-Jae Park; Anthony H Futerman
Journal:  Biochim Biophys Acta       Date:  2013-09-08

2.  Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients.

Authors:  Sharda Anroedh; Mika Hilvo; K Martijn Akkerhuis; Dimple Kauhanen; Kaisa Koistinen; Rohit Oemrawsingh; Patrick Serruys; Robert-Jan van Geuns; Eric Boersma; Reijo Laaksonen; Isabella Kardys
Journal:  J Lipid Res       Date:  2018-06-01       Impact factor: 5.922

Review 3.  Could Ceramides Become the New Cholesterol?

Authors:  Scott A Summers
Journal:  Cell Metab       Date:  2018-01-04       Impact factor: 27.287

4.  CerS2 Haploinsufficiency Inhibits β-Oxidation and Confers Susceptibility to Diet-Induced Steatohepatitis and Insulin Resistance.

Authors:  Suryaprakash Raichur; Siew Tein Wang; Puck Wee Chan; Ying Li; Jianhong Ching; Bhagirath Chaurasia; Shaillay Dogra; Miina K Öhman; Kosuke Takeda; Shigeki Sugii; Yael Pewzner-Jung; Anthony H Futerman; Scott A Summers
Journal:  Cell Metab       Date:  2014-11-04       Impact factor: 27.287

5.  Obesity-induced CerS6-dependent C16:0 ceramide production promotes weight gain and glucose intolerance.

Authors:  Sarah M Turpin; Hayley T Nicholls; Diana M Willmes; Arnaud Mourier; Susanne Brodesser; Claudia M Wunderlich; Jan Mauer; Elaine Xu; Philipp Hammerschmidt; Hella S Brönneke; Aleksandra Trifunovic; Giuseppe LoSasso; F Thomas Wunderlich; Jan-Wilhelm Kornfeld; Matthias Blüher; Martin Krönke; Jens C Brüning
Journal:  Cell Metab       Date:  2014-10-07       Impact factor: 27.287

6.  Plasma Ceramides.

Authors:  Jeffrey W Meeusen; Leslie J Donato; Sandra C Bryant; Linnea M Baudhuin; Peter B Berger; Allan S Jaffe
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

Review 7.  Ceramides - Lipotoxic Inducers of Metabolic Disorders.

Authors:  Bhagirath Chaurasia; Scott A Summers
Journal:  Trends Endocrinol Metab       Date:  2015-10       Impact factor: 12.015

8.  Circulating Sphingolipids, Insulin, HOMA-IR, and HOMA-B: The Strong Heart Family Study.

Authors:  Rozenn N Lemaitre; Chaoyu Yu; Andrew Hoofnagle; Nair Hari; Paul N Jensen; Amanda M Fretts; Jason G Umans; Barbara V Howard; Colleen M Sitlani; David S Siscovick; Irena B King; Nona Sotoodehnia; Barbara McKnight
Journal:  Diabetes       Date:  2018-03-27       Impact factor: 9.461

9.  Molecular lipids identify cardiovascular risk and are efficiently lowered by simvastatin and PCSK9 deficiency.

Authors:  Kirill Tarasov; Kim Ekroos; Matti Suoniemi; Dimple Kauhanen; Tuulia Sylvänne; Reini Hurme; Ioanna Gouni-Berthold; Heiner K Berthold; Marcus E Kleber; Reijo Laaksonen; Winfried März
Journal:  J Clin Endocrinol Metab       Date:  2013-12-20       Impact factor: 5.958

10.  Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol.

Authors:  Reijo Laaksonen; Kim Ekroos; Marko Sysi-Aho; Mika Hilvo; Terhi Vihervaara; Dimple Kauhanen; Matti Suoniemi; Reini Hurme; Winfried März; Hubert Scharnagl; Tatjana Stojakovic; Efthymia Vlachopoulou; Marja-Liisa Lokki; Markku S Nieminen; Roland Klingenberg; Christian M Matter; Thorsten Hornemann; Peter Jüni; Nicolas Rodondi; Lorenz Räber; Stephan Windecker; Baris Gencer; Eva Ringdal Pedersen; Grethe S Tell; Ottar Nygård; Francois Mach; Juha Sinisalo; Thomas F Lüscher
Journal:  Eur Heart J       Date:  2016-04-28       Impact factor: 29.983
View more
  20 in total

1.  Rare DEGS1 variant significantly alters de novo ceramide synthesis pathway.

Authors:  Nicholas B Blackburn; Laura F Michael; Peter J Meikle; Juan M Peralta; Marian Mosior; Scott McAhren; Hai H Bui; Melissa A Bellinger; Corey Giles; Satish Kumar; Ana C Leandro; Marcio Almeida; Jacquelyn M Weir; Michael C Mahaney; Thomas D Dyer; Laura Almasy; John L VandeBerg; Sarah Williams-Blangero; David C Glahn; Ravindranath Duggirala; Mark Kowala; John Blangero; Joanne E Curran
Journal:  J Lipid Res       Date:  2019-06-21       Impact factor: 5.922

2.  Dietary inulin decreases circulating ceramides by suppressing neutral sphingomyelinase expression and activity in mice.

Authors:  Pan Deng; Jessie B Hoffman; Michael C Petriello; Chun-Yan Wang; Xu-Sheng Li; Maria P Kraemer; Andrew J Morris; Bernhard Hennig
Journal:  J Lipid Res       Date:  2019-10-11       Impact factor: 5.922

3.  Ceramide Biomarkers Predictive of Cardiovascular Disease Risk Increase in Healthy Older Adults After Bed Rest.

Authors:  Jonathan J Petrocelli; Alec I McKenzie; Ziad S Mahmassani; Paul T Reidy; Gregory J Stoddard; Annelise M Poss; William L Holland; Scott A Summers; Micah J Drummond
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-09-16       Impact factor: 6.053

Review 4.  Role of ceramides in the pathogenesis of diabetes mellitus and its complications.

Authors:  Nawajes Mandal; Richard Grambergs; Koushik Mondal; Sandip K Basu; Faiza Tahia; Sam Dagogo-Jack
Journal:  J Diabetes Complications       Date:  2020-09-16       Impact factor: 2.852

5.  Characterizing a Common CERS2 Polymorphism in a Mouse Model of Metabolic Disease and in Subjects from the Utah CAD Study.

Authors:  Rebekah J Nicholson; Annelise M Poss; J Alan Maschek; James E Cox; Paul N Hopkins; Steven C Hunt; Mary C Playdon; William L Holland; Scott A Summers
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 6.134

6.  Manipulation of the Sphingolipid Rheostat Influences the Mediator of Flow-Induced Dilation in the Human Microvasculature.

Authors:  Mary E Schulz; Boran Katunaric; Joseph C Hockenberry; David D Gutterman; Julie K Freed
Journal:  J Am Heart Assoc       Date:  2019-08-29       Impact factor: 5.501

7.  Co-exposure to PCB126 and PFOS increases biomarkers associated with cardiovascular disease risk and liver injury in mice.

Authors:  Pan Deng; Chunyan Wang; Banrida Wahlang; Travis Sexton; Andrew J Morris; Bernhard Hennig
Journal:  Toxicol Appl Pharmacol       Date:  2020-10-20       Impact factor: 4.219

8.  Association of Circulating Ceramides With Cardiac Structure and Function in the Community: The Framingham Heart Study.

Authors:  Chike C Nwabuo; Meredith Duncan; Vanessa Xanthakis; Linda R Peterson; Gary F Mitchell; David McManus; Susan Cheng; Ramachandran S Vasan
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

9.  Downregulation of Lysosomal Acid Ceramidase Mediates HMGB1-Induced Migration and Proliferation of Mouse Coronary Arterial Myocytes.

Authors:  Xinxu Yuan; Owais M Bhat; Hannah Lohner; Yang Zhang; Pin-Lan Li
Journal:  Front Cell Dev Biol       Date:  2020-03-10

10.  Analytical considerations for reducing the matrix effect for the sphingolipidome quantification in whole blood.

Authors:  Dezhen Wang; Peining Xu; Clementina Mesaros
Journal:  Bioanalysis       Date:  2021-06-10       Impact factor: 2.681
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.